MARKET

CING

CING

Cingulate Inc
NASDAQ
6.28
-0.43
-6.41%
Opening 13:52 03/25 EDT
OPEN
6.76
PREV CLOSE
6.71
HIGH
6.89
LOW
6.20
VOLUME
402.77K
TURNOVER
--
52 WEEK HIGH
11.89
52 WEEK LOW
3.200
MARKET CAP
73.03M
P/E (TTM)
-1.4142
1D
5D
1M
3M
1Y
5Y
1D
Cingulate Is Maintained at Buy by Roth Capital
Dow Jones · 2d ago
Cingulate Price Target Cut to $14.00/Share From $16.00 by Roth Capital
Dow Jones · 2d ago
Roth Capital Maintains Buy on Cingulate, Lowers Price Target to $14
Benzinga · 2d ago
Weekly Report: what happened at CING last week (0316-0320)?
Weekly Report · 2d ago
Cingulate price target lowered to $14 from $16 at Roth Capital
TipRanks · 2d ago
Analysts Offer Insights on Healthcare Companies: 20/20 Biolabs, Inc. (AIDX) and Cingulate Inc (CING)
TipRanks · 4d ago
What's Going On With Cingulate Stock Today?
Benzinga · 5d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 5d ago
More
About CING
Cingulate Inc. is a biopharmaceutical company. The Company is focused on the development, manufacturing, and commercialization of pharmaceutical products that utilize its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles. It focuses on the treatment of attention deficit/hyperactivity disorder (ADHD). The Company is in the development of two lead product candidates, such as CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). The Company’s CTx-1301 and CTx-1302 are being developed for the treatment of ADHD in the three core patient segments: children (ages 6-12), adolescents (ages 13-17), and adults (ages18+). In addition, the Company has a third product to treat anxiety, CTx-2103, in a formulation stage. Its CTx-1301, CTx-1302 and CTx-2103 drug candidates contain three releases of active pharmaceutical ingredient combined into one small tablet dosage form.

Webull offers Cingulate Inc stock information, including NASDAQ: CING real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CING stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CING stock methods without spending real money on the virtual paper trading platform.